Altria reported Q4 revenue (excluding excise taxes) of $5.08 billion, beating consensus of $5.02 billion, but adjusted EPS came in at $1.30 versus the $1.32 expected. The 5% share price drop followed the earnings release, as investors reacted to the earnings shortfall despite top-line resilience. Management highlighted continued strength in Marlboro pricing, which offset part of the volume declines, and reiterated full-year guidance for flat to low-single-digit revenue growth excluding excise taxes.

Premium Marlboro cigarette volumes plunged 12.6% year-over-year in Q4, outpacing a broader industry decline. Total cigarette shipments fell 10% in the quarter, exacerbating concerns over declining core profitability. The smokeless on! segment continued to lose market share, growing at a pace insufficient to offset cigarette volume losses. Analysts at a major brokerage have assigned a strong sell rating, citing deteriorating fundamentals and limited upside in the domestic tobacco market.

Despite volume headwinds, Altria delivered an all-time high adjusted operating margin, driven by pricing power and operational efficiency. The company’s price elasticity remained manageable, with Marlboro retaining a commanding 59.2% share of the U.S. premium cigarette segment. Management emphasized ongoing cost discipline initiatives and capacity utilization improvements, which supported margin expansion even as unit shipment volumes contracted.